| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 8.099 | 8.016 | 7.881 | 1.289 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Income - EUR | 8.106 | 8.016 | 7.881 | 1.289 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Expenses - EUR | 3.463 | 3.886 | 5.082 | 1.211 | 408 | 233 | 0 | 0 | 0 | 150 |
| Gross Profit/Loss - EUR | 4.643 | 4.130 | 2.799 | 78 | -408 | -233 | 0 | 0 | 0 | -150 |
| Net Profit/Loss - EUR | 4.400 | 3.890 | 2.641 | 59 | -408 | -233 | 0 | 0 | 0 | -150 |
| Employees | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Dagema Intermed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 25 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 0 |
| Current Assets | 4.625 | 8.610 | 11.730 | 10.777 | 10.161 | 9.868 | 9.649 | 9.549 | 9.520 | 9.181 |
| Inventories | 0 | 151 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 675 | 668 | 657 | 645 | 632 | 753 | 606 | 608 | 606 | 603 |
| Cash | 3.950 | 7.791 | 11.074 | 10.133 | 9.528 | 9.115 | 9.043 | 8.940 | 8.913 | 8.578 |
| Shareholders Funds | 4.445 | 8.289 | 10.790 | 10.650 | 10.036 | 9.613 | 9.400 | 9.429 | 9.400 | 9.198 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 206 | 327 | 947 | 133 | 130 | 260 | 255 | 125 | 125 | -16 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4612 - 4612" | |||||||||
| CAEN Financial Year |
4612
|
|||||||||
Comments - Dagema Intermed Srl